{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T02:26:10Z","timestamp":1788575170498,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":4774,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K24-HD01346-01"],"award-info":[{"award-number":["K24-HD01346-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-HD2364"],"award-info":[{"award-number":["R01-HD2364"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","fertstert.org","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.fertnstert.2008.02.101","type":"journal-article","created":{"date-parts":[[2008,4,26]],"date-time":"2008-04-26T15:09:02Z","timestamp":1209222542000},"page":"1848-1852","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Dehydroepiandrosterone sulfate and insulin resistance in patients with polycystic ovary syndrome"],"prefix":"10.1016","volume":"91","author":[{"given":"Kathleen","family":"Brennan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Azziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2008.02.101_bib1","first-page":"3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.02.101_bib2","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1210\/jcem.84.11.6148","article-title":"A survey of the polycystic ovary syndrome in the Greek island of Lesbos: a hormonal and metabolic profile","volume":"84","author":"Diamanti-Kandarakis","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.02.101_bib3","first-page":"2434","article-title":"A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain","volume":"85","author":"Asuncion","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.02.101_bib4","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.02.101_bib5","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.fertnstert.2004.11.070","article-title":"Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment","volume":"83","author":"DeUgarte","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.02.101_bib6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejogrb.2005.11.012","article-title":"The association of serum androgens and insulin resistance with fat distribution in polycystic ovary syndrome","volume":"126","author":"Yucel","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2008.02.101_bib7","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1210\/jcem-62-5-904","article-title":"Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism","volume":"62","author":"Barbieri","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.02.101_bib8","first-page":"2001","article-title":"Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositol-glycan mediators as the signal transduction system","volume":"83","author":"Nestler","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.02.101_bib9","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0015-0282(16)54738-4","article-title":"No acute effect of physiologic insulin increase on dehydroepiandrosterone sulfate in women with obesity and\/or polycystic ovarian disease","volume":"56","author":"Buyalos","year":"1991","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.02.101_bib10","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0015-0282(01)02014-3","article-title":"Influence of insulin and testosterone on adrenocortical steroidogenesis in vitro: preliminary studies","volume":"76","author":"Hines","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.02.101_bib11","first-page":"727","article-title":"Effects of dehydroepiandrosterone on gluconeogenic enzymes and glucose uptake in human hepatoma cell line, HepG2","volume":"52","author":"Yamashita","year":"2005","journal-title":"Endocrinol J"},{"key":"10.1016\/j.fertnstert.2008.02.101_bib12","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2337\/diab.40.6.693","article-title":"Opposing actions of dehydroepiandrosterone and testosterone on insulin sensitivity. In vivo and in vitro studies of hyperandrogenic females","volume":"40","author":"Buffington","year":"1991","journal-title":"Diabetes"},{"key":"10.1016\/j.fertnstert.2008.02.101_bib13","first-page":"923","article-title":"A relationship between dehydroepiandrosterone sulfate and insulin resistance in obese men and women","volume":"50","author":"Mottl","year":"2004","journal-title":"Vnitr Lek"},{"key":"10.1016\/j.fertnstert.2008.02.101_bib14","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1056\/NEJM198612113152405","article-title":"A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease","volume":"315","author":"Barrett-Connor","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2008.02.101_bib15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/01.CIR.89.1.89","article-title":"Evidence for an association between dehydroepiandrosterone sulfate and nonfatal premature myocardial infarction in males","volume":"89","author":"Mitchell","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.fertnstert.2008.02.101_bib16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/aje\/153.1.79","article-title":"Low dehydroepiandrosterone and ischemic heart diseases in middle-aged men: prospective results from the Massachusetts Male Aging Study","volume":"153","author":"Feldman","year":"2001","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.fertnstert.2008.02.101_bib17","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.metabol.2004.12.011","article-title":"Association of decrease in serum dehydroepiandrosterone sulfate levels with the progression to type 2 diabetes in men of a Japanese population: the Fungata Study","volume":"54","author":"Kameda","year":"2005","journal-title":"Metabolism"},{"key":"10.1016\/j.fertnstert.2008.02.101_bib18","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1210\/jcem-59-3-551","article-title":"Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood","volume":"59","author":"Orentreich","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.02.101_bib19","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1172\/JCI110908","article-title":"Mechanism of insulin resistance in aging","volume":"71","author":"Fink","year":"1983","journal-title":"J Clin Invest"},{"key":"10.1016\/j.fertnstert.2008.02.101_bib20","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1172\/JCI110914","article-title":"Characterization of the insulin resistance in aging","volume":"71","author":"Rowe","year":"1983","journal-title":"J Clin Invest"},{"key":"10.1016\/j.fertnstert.2008.02.101_bib21","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0026-0495(97)90231-6","article-title":"Insulin resistance and advancing age: what role for dehydroepiandrosterone sulfate?","volume":"46","author":"Paolisso","year":"1997","journal-title":"Metabolism"},{"key":"10.1016\/j.fertnstert.2008.02.101_bib22","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S1043-2760(02)00617-3","article-title":"DHEA treatment: myth or reality?","volume":"13","author":"Allolio","year":"2002","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.02.101_bib23","doi-asserted-by":"crossref","first-page":"830","DOI":"10.2337\/diab.31.9.830","article-title":"Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice","volume":"31","author":"Coleman","year":"1982","journal-title":"Diabetes"},{"key":"10.1016\/j.fertnstert.2008.02.101_bib24","series-title":"Insulin resistance and polycystic ovarian syndrome: pathogenesis, evaluation, and treatment","first-page":"145","article-title":"Evaluation for insulin resistance and co-morbidities related to insulin resistance in PCOS","author":"Azziz","year":"2007"},{"key":"10.1016\/j.fertnstert.2008.02.101_bib25","series-title":"Polycystic ovary syndrome","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome: towards a rational approach","author":"Zawadzki","year":"1992"},{"key":"10.1016\/j.fertnstert.2008.02.101_bib26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.02.101_bib27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.02.101_bib28","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Androgen Excess Society. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.02.101_bib29","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0002-9378(81)90746-8","article-title":"Hirsutism: implications, etiology, and management","volume":"140","author":"Hatch","year":"1981","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2008.02.101_bib30","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/0002-9378(95)91488-9","article-title":"Chronic hyperinsulinemia and the adrenal androgen response to acute corticotropin-(1-24) stimulation in hyperandrogenic women","volume":"172","author":"Azziz","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2008.02.101_bib31","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1210\/jcem-27-7-1012","article-title":"Testosterone-binding levels in the serum of women during the normal menstrual cycle, pregnancy, and the postpartum","volume":"27","author":"Pearlman","year":"1967","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.02.101_bib32","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.fertnstert.2008.02.101_bib33","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11154-007-9054-0","article-title":"The adrenal and polycystic ovary syndrome","volume":"8","author":"Yildiz","year":"2007","journal-title":"Rev Endocrinol Metab Disord"},{"key":"10.1016\/j.fertnstert.2008.02.101_bib34","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.fertnstert.2003.05.008","article-title":"Glucose action and andrenocortical biosynthesis in women with polycystic ovary syndrome","volume":"81","author":"Farah-Eways","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.02.101_bib35","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1210\/jc.2003-031205","article-title":"Failure of mathematical indices to accurately assess insulin resistance in lean, overweight, or obese women with polycystic ovary syndrome","volume":"89","author":"Diamonti-Kandarakis","year":"2004","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001502820800366X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001502820800366X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T18:40:38Z","timestamp":1737398438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001502820800366X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S001502820800366X"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2008.02.101","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dehydroepiandrosterone sulfate and insulin resistance in patients with polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2008.02.101","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}